Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$4.26 - $6.5 $4,260 - $6,500
-1,000 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$5.03 - $8.8 $5,030 - $8,800
1,000 New
1,000 $6,000
Q3 2019

Oct 09, 2019

SELL
$13.89 - $23.16 $1,041 - $1,737
-75 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$2.45 - $16.27 $183 - $1,220
75 New
75 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Bedel Financial Consulting, Inc. Portfolio

Follow Bedel Financial Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.